Perioperative systemic treatments in renal cell carcinoma

被引：3
|
作者：
Goswamy, Rohit [1 ,2 ]
Kalemoglu, Ecem [3 ]
Master, Viraj [2 ,4 ]
Bilen, Mehmet Asim [1 ,2 ]
机构：
[1] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA USA
[4] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词：
renal cell carcinoma; neoadjuvant; adjuvant; kidney cancer; review; cancer; RCC (Renal Cell Carcinoma); outcomes; NIVOLUMAB PLUS CABOZANTINIB; HIGH-RISK; INTERFERON-ALPHA; PHASE-III; FOLLOW-UP; NEOADJUVANT AXITINIB; SURGICAL-MANAGEMENT; ADJUVANT PAZOPANIB; SURVIVAL ANALYSIS; DOUBLE-BLIND;
D O I：
10.3389/fonc.2024.1362172
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this review, we aim to provide a comprehensive assessment of the evolving landscape of the perioperative management in renal cell carcinoma (RCC), emphasizing its dynamic and intricate nature. We explore academic and clinical insights into the perioperative treatment paradigm of RCC. Up-to-date treatment options are discussed and the evolving role of neoadjuvant and adjuvant therapy in RCC is highlighted.
引用
收藏
页数：15
相关论文
共 50 条
  • [41] Current and Emerging Treatments for Metastatic Renal Cell Carcinoma
    Cavaliere, Carla
    D'Aniello, Carmine
    Della Pepa, Chiara
    Pisconti, Salvatore
    Berretta, Massimiliano
    Facchini, Gaetano
    CURRENT CANCER DRUG TARGETS, 2018, 18 (05) : 468 - 479
  • [42] New Treatments for Renal Cell Carcinoma: Targeted Therapies
    Saylor, Philip J.
    Michaelson, M. Dror
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (06): : 645 - 656
  • [43] Antiangiogenic treatments and mechanisms of action in renal cell carcinoma
    Sylvie Négrier
    Eric Raymond
    Investigational New Drugs, 2012, 30 : 1791 - 1801
  • [44] Antiangiogenic treatments and mechanisms of action in renal cell carcinoma
    Negrier, Sylvie
    Raymond, Eric
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1791 - 1801
  • [45] Renal cell carcinoma: novel treatments for advanced disease
    Huland, E
    Heinzer, H
    CURRENT OPINION IN UROLOGY, 2003, 13 (06) : 451 - 456
  • [46] Renal cell carcinoma in functional renal graft: Toward ablative treatments
    Tillou, Xavier
    Guleryuz, Kerem
    Collon, Sylvie
    Doerfler, Arnaud
    TRANSPLANTATION REVIEWS, 2016, 30 (01) : 20 - 26
  • [47] Aktuelle Konzepte für die perioperative Systemtherapie beim fortgeschrittenen NierenzellkarzinomCurrent concepts for perioperative systemic therapy in advanced renal cell carcinoma
    Thomas Hilser
    Markus Kuczyk
    Christopher Darr
    Viktor Grünwald
    Die Urologie, 2022, 61 (12) : 1345 - 1350
  • [48] PERIOPERATIVE IMMUNE PROFILES IN PATIENTS WITH RENAL-CELL CARCINOMA
    DANIEL, V
    POMER, S
    OPELZ, G
    DREIKORN, K
    ROHL, L
    UROLOGICAL RESEARCH, 1986, 14 (03): : 172 - 172
  • [49] Perioperative complications associated to nephrectomy in metastatic renal cell carcinoma
    Cruz-Ruiz, Jose
    Alberto Cayetano-Alcaraz, Axel
    Mario Chamlati-Cuello, Jorge
    Rodriguez-Covarrubias, Francisco
    GACETA MEXICANA DE ONCOLOGIA, 2019, 18 (02): : 22 - 26
  • [50] SYSTEMIC MANIFESTATIONS CARCINOMA .2. SYSTEMIC MANIFESTATIONS OF RENAL-CELL CARCINOMA
    STRAFFON, RA
    AMERICAN PRACTITIONER AND DIGEST OF TREATMENT, 1961, 12 (09): : 645 - &
12345